Update: First Trials in Abilify Gambling Litigation to Begin in June
April 23, 2018 – Lawsuits involving allegations of uncontrollable gambling addictions and other compulsive behavior disorders resulting from use of Abilify are scheduled to begin this summer in the U.S. District Court, District of Florida, where all such federal claims have been consolidated into a multidistrict litigation (MDL) for pretrial handling. According to a recent order by U.S. District Judge Casey Rodgers, 3 bellwether trials have been chosen to kick off the proceedings, the first of which is slated to begin on August 6.
What is Abilify?
Abilify (generic: aripiprazole) is an antipsychotic medication used to treat the symptoms of schizophrenia, bipolar disorder, and other depressive disorders in adults. The drug may also be prescribed for irritability, aggression, mood swings, temper tantrums and self-injury related to autistic disorder in children who are at least 6 years old. Abilify is made by Bristol-Myers Squibb, and was approved by the U.S. Food & Drug Administration (FDA) in 2002.
Abilify and Diabetes
In August 2013, a study published in JAMA Psychiatry found that children who use antipsychotic drugs like Abilify have a 3-fold increased risk of developing type 2 diabetes. While earlier studies had identified the link between antipsychotics and diabetes, the JAMA study represented the first large, well-designed study to look at the risk in pediatric patients. The researchers noted that the use of this class of drugs for non-psychosis-related disorders in children currently accounts for the majority of prescriptions.
Abilify Side Effects
- Type 2 diabetes
- Stroke & ministroke
- Difficulty speaking
- Loss of balance control
- Muscle trembling, jerking, or stiffness
- Shuffling walk
- Stiffness of the limbs
- Twisting / uncontrolled movements of the body
- Compulsive behavior
- And more
Abilify Seriously Harms Your Impulse Control Center: Ring of Fire Video
Abilify and Pregnancy
In February 2011, the FDA issued a Drug Safety Communication alerting patients to a risk of harm to unborn babies whose mothers take antipsychotic drugs like Abilify during pregnancy. According to the warning, the drugs could cause abnormal muscle movements and withdrawal symptoms in infants exposed during the third trimester. As a result of these problems, the agency required that the entire class of antipsychotic drug labels be updated with information about the risk of potential fetal harm.
Is There a Class Action?
At this time, no class action lawsuit has been filed in the Abilify litigation. However, our lawyers are currently reviewing individual lawsuits for people who were diagnosed with type 2 diabetes after taking the drug. Contact us today to learn more about your legal rights. If we determine that you have a valid claim, you may be eligible to receive compensation for medical expenses, lost wages, pain and suffering, and other damages.
Abilify Lawsuit Filed in Minnesota
October 18, 2016 – Side effects of Abilify caused a Minnesota woman to rack up a large amount of debt as a result of compulsive gambling, according to a recent lawsuit. Plaintiff Denise Miley alleges that she began suffering uncontrollable urges to gamble shortly after she began taking Abilify in September 2014. Her need to gamble went away after quitting the drug in February 2015, but by that time she had already accumulated in excess of $75,000 in debt, according to the complaint.
Abilify Gambling Lawsuits Centralized in Florida Federal Court
October 6, 2016 – A multidistrict litigation (MDL No. 2734) has been created in the Northern District of Florida for federal lawsuits alleging pathological gambling side effects from Abilify. There are currently at least 22 such complaints pending in 12 different jurisdictions, in addition to another 20 actions in 14 districts the judges were recently notified about, according to the Transfer Order (PDF).
Bristol-Myers Requests Florida as Venue for Abilify Gambling MDL
October 3, 2016 – Bristol-Myers has filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to send dozens of lawsuits alleging compulsive gambling side effects from Abilify to federal court in Pensacola, Florida. The drugmaker contends that the Northern District of Florida makes sense since 13 Abilify lawsuits have already been consolidated in New Jersey state court, and that other plaintiffs have consented to the proposed jurisdiction.
Abilify Labeling Updated to Include Gambling, Compulsive Behaviors Warning
August 24, 2016 – The U.S. Food & Drug Administration (FDA) has revised the labeling of Abilify to include a warning (PDF) for “pathological gambling and other compulsive behaviors.” The warning notes that patients may not recognize such behaviors as abnormal, counsels physicians to ask about such behaviors, and recommends discontinuation or dose reduction if these behaviors appear.
Massachusetts Woman Alleges Compulsive Behaviors from Abilify
July 28, 2016 – Rikki Carlson of Fall River, Massachusetts, has filed a personal injury lawsuit against Bristol-Myers Squibb and Otsuka Pharmaceutical, alleging that her use of Abilify caused her to have compulsive behaviors including gambling, shopping and binge eating. Carlson says she started taking Abilify in or around December 2010, and began compulsively gambling and shopping shortly thereafter; these behaviors ceased promptly after she quit the drug in March 2016, according to the complaint.
Public Citizen Demands ‘Black Box Warning’ on Antipsychotic Meds
July 17, 2016 – The watchdog group Public Citizen sent a petition (PDF) last month to the FDA requesting ‘black box warnings’ to dopamine agonist antipsychotic drugs regarding an increased risk for compulsive behaviors such as gambling, sexual obsessions and shopping. According to the letter, more than 80 studies link these medications to compulsive behaviors. Although the petition did not focus specifically on Abilify, but it did acknowledge data indicating that it was related to the same side effects.
Abilify Gambling Lawsuits May Be Headed for Consolidation
June 30, 2016 – More than 2 dozen lawsuits alleging that Abilify caused gambling addiction and other compulsive behaviors could soon be formed into a multidistrict litigation (MDL), according to Reuters. There are currently at least 26 such complaints pending in federal courts around the country, in addition to 13 cases in New Jersey state court that have already been consolidated. The Motion for Transfer requests that the U.S. Judicial Panel on Multidistrict Litigation (JPML) expedite the matter and schedule oral arguments for its next hearing session, which is set for July 28 in Seattle. The proposed consolidation is In Re: Abilify Compulsive Behavior Products Liability Litigation – MDL No. 2734.
Abilify Labeling Updated to Include Compulsive Behavior Warning
May 3, 2016 – FDA is warning that use of Abilify or other aripiprazole-containing antipsychotic drugs may increase compulsive or uncontrollable urges to gamble, binge eat, shop and have sex. The agency warned that the impulsive behaviors, though rare, may cause harm to the patient or others if not identified. FDA is requiring the addition of new warnings to include these behaviors in the drug labels and Medication Guides for all aripiprazole-containing medications.
Do I Have an Abilify Diabetes Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Abilify lawsuits. We are handling individual litigation nationwide and currently investigating potential settlements in all 50 states.
Free Confidential Case Evaluation: Again, if you were injured by the side effects of Abilify, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and our lawyers can help.